Pyridine → HCID 22987976, compound
Reaction equation
[F:1][C:2]([F:7])([F:6])[C:3]([OH:5])=[O:4].[NH2:8][C:9]1[CH:14]=[C:13]([C:15]2[NH:23][C:18]3=[N:19][CH:20]=[CH:21][N:22]=[C:17]3[C:16]=2[C:24]2[CH:29]=[CH:28][C:27]([F:30])=[CH:26][CH:25]=2)[CH:12]=[CH:11][N:10]=1.N1C=CC=CC=1.[C:37](Cl)(=[O:39])[CH3:38]>O1CCCC1.CO>[F:1][C:2]([F:7])([F:6])[C:3]([OH:5])=[O:4].[C:37]([NH:8][C:9]1[CH:14]=[C:13]([C:15]2[NH:23][C:18]3=[N:19][CH:20]=[CH:21][N:22]=[C:17]3[C:16]=2[C:24]2[CH:29]=[CH:28][C:27]([F:30])=[CH:26][CH:25]=2)[CH:12]=[CH:11][N:10]=1)(=[O:39])[CH3:38]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
6-(2-Aminopyridin-4-yl)-7-(4-fluorophenyl)-5H-pyrrolo[2,3-b]pyrazine trifluoroacetate salt (0.085 g, 0.28 mmol) was dissolved in tetrahydrofuran and pyridine (0.22 g, 2.8 mmol) was added. Acetyl chloride (0.033 g, 0.42 mmol) in tetrahydrofuran (1 ml) was added and the resulting mixture was stirred at room temperature. After 1 h, the reaction mixture was diluted with methanol (2 ml) and the product was isolated by reverse phase HPLC to give 6-(2-acetylaminopyridin-4-yl)-7-(4-fluorophenyl)-5H-pyrrolo[2,3-b]pyrazine trifluoroacetate salt (0.1 g) as a yellow solid. The product was converted to the hydrochloride salt by suspending the product in ether and adding 1.0M solution of HCl in ether (2 ml) to give a solid which was filtered off to give 6-(2-acetylaminopyridin-4-yl)-7-(4-fluorophenyl)-5H-pyrrolo[2,3-b]pyrazine hydrochloride salt (0.0.44 g) as a yellow solid.
Workup
- customthe product was isolated by reverse phase HPLC
Sources & evidence
- ORD record
- ord-f100f95751e34d6291c66c5ee49d9525
- Source dataset
- uspto-grants-2001_11
- Patent number
- US06316464B1
Reaction notes
Loading…